Related Diseases
Depression
Size
250.0mg; 500.0mg; 1.0g
Description
Metyrapone is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). It blocks cortisol synthesis by reversibly inhibiting steroid 11β-hydroxylase. This stimulates ACTH secretion, which in turn increases plasma 11-deoxycortisol levels.
Chemical Formula
C14H14N2O
Molecular Weight
226.2738
Elemental Analysis
C, 74.31; H, 6.24; N, 12.38; O, 7.07
Synonym
Metyrapone, Metopirone, SU 4885, Methbipyranone, Methopyrapone
IUPAC/Chemical Name
2-methyl-1,2-dipyridin-3-ylpropan-1-one
InChi Key
FJLBFSROUSIWMA-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3
SMILES Code
CC(C1=CC=CN=C1)(C)C(C2=CC=CN=C2)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001